/PRNewswire/ Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, today announced the company has closed on a $31.
DJ Arix Bioscience PLC: Arix Bioscience co-leads USD31 million Series A financing for new portfolio company Sorriso Pharmaceuticals Arix Bioscience PLC (ARIX) Arix Bioscience PLC: Arix Bioscience
Arix Bioscience co-leads $31 million Series A financing for new portfolio companySorriso Pharmaceuticals Arix announces a new portfolio company, Sorriso, with a 26% ownership stakeSeries A proceeds will enable Sorriso Pharmaceuticals to advance its lead programme, a treatment for IBD, into clinical trialsArix M.
New Providence, NJ (PRWEB) October 27, 2021 Kiswe, the interactive video company, today announced Sony Innovation Fund by IGV has invested in the company